JP2013502442A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013502442A5 JP2013502442A5 JP2012525830A JP2012525830A JP2013502442A5 JP 2013502442 A5 JP2013502442 A5 JP 2013502442A5 JP 2012525830 A JP2012525830 A JP 2012525830A JP 2012525830 A JP2012525830 A JP 2012525830A JP 2013502442 A5 JP2013502442 A5 JP 2013502442A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- tetrahydroxy
- cholan
- bile
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23675009P | 2009-08-25 | 2009-08-25 | |
| US61/236,750 | 2009-08-25 | ||
| PCT/CA2010/001338 WO2011022838A1 (en) | 2009-08-25 | 2010-08-25 | Polyhydroxylated bile acids for treatment of biliary disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013502442A JP2013502442A (ja) | 2013-01-24 |
| JP2013502442A5 true JP2013502442A5 (https=) | 2013-10-10 |
| JP5909774B2 JP5909774B2 (ja) | 2016-04-27 |
Family
ID=43627124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012525830A Active JP5909774B2 (ja) | 2009-08-25 | 2010-08-25 | 胆道疾患を治療するためのポリヒドロキシル化胆汁酸 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP2470553B1 (https=) |
| JP (1) | JP5909774B2 (https=) |
| CN (1) | CN102712672B (https=) |
| AU (1) | AU2010286253A1 (https=) |
| BR (1) | BR112012004284B8 (https=) |
| SG (1) | SG178562A1 (https=) |
| WO (1) | WO2011022838A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013041519A1 (en) | 2011-09-19 | 2013-03-28 | ETH Zürich, ETH Transfer | Ror gamma modulators |
| US20130108573A1 (en) | 2011-10-28 | 2013-05-02 | Lumena Pharmaceuticals, Inc. | Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
| AU2012328526B2 (en) | 2011-10-28 | 2017-05-25 | Shire Human Genetic Therapies, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| US9982008B2 (en) | 2012-06-19 | 2018-05-29 | Intercept Pharmaceuticals, Inc. | Preparation and uses of obeticholic acid |
| NZ734451A (en) | 2012-06-19 | 2018-12-21 | Intercept Pharmaceuticals Inc | Preparation, uses and solid forms of obeticholic acid |
| SG11201503697TA (en) * | 2012-11-28 | 2015-06-29 | Intercept Pharmaceuticals Inc | Treatment of pulmonary disease |
| EP2781217A1 (en) * | 2013-03-18 | 2014-09-24 | ETH Zurich | ROR gamma modulators |
| JP6556129B2 (ja) * | 2013-08-01 | 2019-08-07 | アメリカ合衆国 | ファルネソイドｘ受容体の阻害剤及び医薬としての使用 |
| CN104523703A (zh) * | 2014-12-24 | 2015-04-22 | 聂飚 | 一种游离脂肪酸转运蛋白小分子抑制物的应用 |
| US12186329B2 (en) | 2018-08-23 | 2025-01-07 | President And Fellows Of Harvard College | Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes |
| EP3890745B1 (en) | 2018-12-04 | 2025-11-19 | President and Fellows of Harvard College | Synthetic derivatives of cholic acid 7-sulfate and uses thereof |
| KR102204406B1 (ko) * | 2019-01-23 | 2021-01-18 | (주)샤페론 | 타우로데옥시콜린산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 염증성 장질환 예방 또는 치료용 조성물 |
| CN109762043B (zh) * | 2019-03-06 | 2020-07-24 | 华南理工大学 | 鹅去氧胆酸及其制备方法 |
| KR20250171471A (ko) | 2019-05-10 | 2025-12-08 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 장 박테리아 담즙산 대사의 소분자 조정제 |
| CN116925168A (zh) * | 2019-08-23 | 2023-10-24 | 深圳云合医药科技合伙企业(有限合伙) | 胆汁酸衍生物及其组合物和应用 |
| CN110548037B (zh) * | 2019-09-24 | 2023-06-02 | 江西天元药业有限公司 | 精制熊胆粉及其增强体质治疗和预防肿瘤和癌症的用途 |
| CN113024624B (zh) * | 2019-12-25 | 2024-09-10 | 上海科胜药物研发有限公司 | 一种去氧胆酸的合成方法 |
| WO2022233398A1 (en) | 2021-05-04 | 2022-11-10 | Kostner Pharma Gmbh | COMPOUNDS FOR REDUCING LIPOPROTEIN(a) |
| CN115337312B (zh) * | 2022-08-19 | 2025-06-03 | 金熊药业(珠海横琴)有限公司 | 胆酸复合物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS632932A (ja) * | 1986-06-23 | 1988-01-07 | Teijin Ltd | 経鼻投与用粉末状組成物 |
| US7303768B2 (en) * | 1998-07-24 | 2007-12-04 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| RU2224523C2 (ru) * | 1998-07-24 | 2004-02-27 | Сео Хонг Ю | Водный раствор, содержащий желчную кислоту, и способ его получения |
| WO2006116814A1 (en) * | 2005-05-02 | 2006-11-09 | Vanadis Bioscience Ltd | Composition and uses thereof |
| US20090232913A1 (en) * | 2005-05-02 | 2009-09-17 | Momir Mikov | Composition for the Control of Cholesterol Levels |
| US20110263546A1 (en) * | 2008-02-26 | 2011-10-27 | Renxue Wang | Polyhydroxylated Bile Acids for Treatment of Biliary Disorders |
-
2010
- 2010-08-25 EP EP10811080.0A patent/EP2470553B1/en active Active
- 2010-08-25 BR BR112012004284A patent/BR112012004284B8/pt active IP Right Grant
- 2010-08-25 JP JP2012525830A patent/JP5909774B2/ja active Active
- 2010-08-25 CN CN201080048314.9A patent/CN102712672B/zh active Active
- 2010-08-25 WO PCT/CA2010/001338 patent/WO2011022838A1/en not_active Ceased
- 2010-08-25 AU AU2010286253A patent/AU2010286253A1/en not_active Abandoned
- 2010-08-25 SG SG2012013132A patent/SG178562A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013502442A5 (https=) | ||
| JP2018507914A5 (https=) | ||
| WO2010121128A3 (en) | Compositions and methods for treating or inhibiting liver injury | |
| JP2019507781A5 (https=) | ||
| WO2008057420A3 (en) | Extended triterpene derivatives | |
| EA201790124A1 (ru) | Соли берберина, соли урсодезоксихолевой кислоты и их комбинации, способы получения и применения | |
| JP2024500309A5 (https=) | ||
| SG10201903512SA (en) | Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases | |
| WO2007101873A3 (en) | Betulonic acid esters and betulinic acid polyalkylene-glycol derivatives for the treatment of viral infection and cancer | |
| JP2017515854A5 (https=) | ||
| JP2015512953A5 (https=) | ||
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| NZ586751A (en) | Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function | |
| JP2016506391A5 (https=) | ||
| JP2010510210A5 (https=) | ||
| WO2009028457A1 (ja) | 非アルコール性脂肪肝炎治療薬 | |
| JP2013509411A5 (https=) | ||
| WO2010065950A3 (en) | Albumin binding peptide-mediated disease targeting | |
| CN113164498A (zh) | 用于肝病的治疗的组合疗法 | |
| JP2016530279A5 (https=) | ||
| CY1116601T1 (el) | Φαρμακευτικη συνθεση που βασιζεται σε ηπατοπροστατευτικο παραγοντα και πρεβιοτικο, η παραγωγη και χρηση της | |
| JP2020504129A (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| JP2021535175A5 (https=) | ||
| JP2012511510A5 (https=) | ||
| RU2019110779A (ru) | Новые схемы введения агонистов fxr |